Clinical Trial Update: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating adjuvant therapy with TQB3616 plus endocrine therapy versus placebo plus endocrine therapy in breast cancer; the trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TQB3616

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING